The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-Ethylsulfanyl-3-methyl-pyridin-2-ylmethanesulfinyl)-1-methylsulfanylmethyl-1H-benzoimidazole ID: ALA273448
PubChem CID: 14894188
Max Phase: Preclinical
Molecular Formula: C18H21N3OS3
Molecular Weight: 391.59
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCSc1ccnc(C[S+]([O-])c2nc3ccccc3n2CSC)c1C
Standard InChI: InChI=1S/C18H21N3OS3/c1-4-24-17-9-10-19-15(13(17)2)11-25(22)18-20-14-7-5-6-8-16(14)21(18)12-23-3/h5-10H,4,11-12H2,1-3H3
Standard InChI Key: NJDNYXISRUWZSD-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
5.1358 -3.3945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2243 -4.2243 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8977 -3.0605 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4142 -2.9858 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.0369 -4.3957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4492 -3.6761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6968 -3.4027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9773 -2.9904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9844 -2.1618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6103 -4.7815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2635 -3.4093 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4156 -2.1587 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.2648 -1.7494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2720 -0.9208 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.7823 -5.5913 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.5460 -2.9934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5418 -2.1679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4668 -5.1156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6977 -1.7522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2840 -3.6723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5524 -0.5085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1684 -6.1485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2943 -5.1077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5486 0.3263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7029 -4.3860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 2 0
4 1 1 0
5 2 1 0
6 3 1 0
7 4 1 0
8 7 1 0
9 8 1 0
10 2 1 0
11 8 2 0
12 4 1 0
13 9 2 0
14 13 1 0
15 10 1 0
16 11 1 0
17 16 2 0
18 5 2 0
19 9 1 0
20 6 2 0
21 14 1 0
22 15 1 0
23 18 1 0
24 21 1 0
25 20 1 0
5 6 1 0
23 25 2 0
17 13 1 0
M CHG 2 4 1 12 -1
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 391.59Molecular Weight (Monoisotopic): 391.0847AlogP: 4.48#Rotatable Bonds: 7Polar Surface Area: 53.77Molecular Species: NEUTRALHBA: 6HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.08CX Basic pKa: 2.86CX LogP: 4.04CX LogD: 4.04Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.44Np Likeness Score: -1.11
References 1. Sih JC, Im WB, Robert A, Graber DR, Blakeman DP.. (1991) Studies on (H(+)-K+)-ATPase inhibitors of gastric acid secretion. Prodrugs of 2-[(2-pyridinylmethyl)sulfinyl]benzimidazole proton-pump inhibitors., 34 (3): [PMID:1848293 ] [10.1021/jm00107a026 ]